Published for parasitologists, medical and veterinary researchers and emphasizes modern approaches to parasitology, including molecular biology and immunology. Features articles and research papers on the physiological, metabolic, immunologic, biochemical, nutritional and chemotherapeutic aspects of parasites and host-parasite relationships.

Impact factor:2.818 (Source: SJR)Journal Ranking:30/83 in Physiology (Source: ISI, 2015)Circulation:The figure is not currently disclosed.Frequency:12 issues a year.Aims of the journal:Experimental Physiology aims to benefit the world of research by virtue of furthering the  knowledge of pathophysiological mechanisms in diseases.Content:Experimental Physiology is a peer-reviewed journal publishing high quality, original, physiological research papers that give novel insights into fundamental homeostatic and adaptive responses in health and papers that further our knowledge of pathophysiological mechanisms in diseases.Editorial contacts:Please see the full list of editorial contacts here.Manuscript submission:For manuscript submission, please access here.See the guidelines for submission here. Wiley Online Library author guidelines can be found at: onlinelibrary.wiley.com

Publication of the Society for Experimental Mechanics. Contain reports on applications in the field of stress analysis in engineering and mechanical design. Designed for the practicing engineer or technician who must find ingenious means to collect testing and measurement data. Also offers the information on the latest commercially available hardware and software.

Published primarily for mechanical, chemical, aerospace and nuclear engineers. Emphasizes experimental work that enhances basic understanding of heat transfer, thermodynamics, fluid mechanics, and their applications. Covers topics such as combined heat and mass transfer, multiphase flow, combustion, radiative transfer, porous media, cryogenics, turbulence, contact resistance and thermophysical property measurements and techniques.

Designed as a results-oriented resource for plaintiff and defense lawyers. Tracks the latest state and federal news and support relating to expert evidence. Coverage includes court rulings on discoverability, admissibility and sufficiency of expert evidence; legislative proposals and changes to federal laws. Offers case studies, reports on trends and developments, discussion forums, as well as courtroom tips.

Expert Market is an online platform expert in supplies, software, and services for business.

Impact Factor: 3.484. (Thomson Reuters 2015) Journal Ranking: 62/253 in Pharmacology & Pharmacy (Thomson Reuters Journal Citation Report 2015) Circulation: A figure is not disclosed. Aims of the journal: It provides a forum for the commentary and analysis of drug discovery in the post-genomic era, with emphasis placed on the current and emerging disciplines involved and strategic planning. It is international, MEDLINE-indexed and peer-reviewed that publishes review articles covering all aspects of drug delivery research, from initial concept to potential therapeutic application and final relevance in clinical use. Each article is structured to incorporate the author’s own expert opinion on the scope for future development. Content: It covers chemoinformatics reviews - bioinformatics; assay development; novel screening technologies, in vitro/in vivo models, structure-based drug design, systems biology and drug case histories examining the steps involved in the preclinical and clinical development. Readership: Scientists and healthcare and pharmaceutical managers, academic pharmaceutical scientists and others closely involved in the delivery of drugs and other therapeutic agents. Editorial contacts: All editorial queries should be sent to Commissioning Editor David Grech at david.grech@informa.com Manuscript Submission: Information for authors can be found here. Submission can be found here.

Impact Factor: 0.464 (© 2015 Thomson Reuters, Journal Citation Reports®) Circulation: The Publisher does not disclose the circulation. Aims of the Journal: Expert Opinion on Orphan Drugs is an international, peer-reviewed journal that covers all aspects of R&D on rare diseases and orphan drugs. The Editors welcome: Reviews that focus on rare diseases or orphan drugs, and report on any of the following topics: diagnostics, pharmacogenomics and screening; prevalence and epidemiology (with particular attention to regional variations); drug development; lead generation and discovery; early or late phase clinical trials; regulatory issues; post-marketing safety; treatment outcomes. Drug Evaluations specifically reviewing the pharmacological properties; clinical potential/clinical efficacy; safety and, if applicable, HE/OR data on a particular orphan drug. Original Research papers reporting the results of early or late stage clinical investigations or HE/OR data on orphan drugs and studies in the treatment of rare diseases. Editorials, commentaries and meeting-highlights papers covering topics in rare diseases. Instructions for Authors / Submission Guidance: This can be found here

Impact Factor: 4.626 (Source: 2015 ISI) Journal Ranking:  4/59 Chemistry, Medicinal; 31/253 Pharmacology & Pharmacy. Source: Thomson Reuters Journal Citation Reports 2015 Circulation: The Publisher does not disclose the circulation. Aims of the journal: Expert Opinion on Therapeutic Patents is a MEDLINE-indexed, peer-reviewed, international journal publishing review articles on recent pharmaceutical patent claims, providing expert opinion the scope for future development, in the context of the scientific literature. Readership: The audience consists of scientists, managers and decision-makers in the pharmaceutical industry and others closely involved in R&D. Content: The Editors welcome: Reviews covering recent patent claims on compounds or applications with therapeutic potential, including biotherapeutics and small-molecule agents with specific molecular targets; and patenting trends in a particular therapeutic area Patent Evaluations examining the aims and chemical and biological claims of individual patents Perspectives on issues relating to intellectual property Manuscript submission: Instructions for authors can be viewed here Online submission here

Impact Factor: 4.798 (Source: Thomson Reuters Journal Citation Reports 2015) Journal Ranking: 28/253 Pharmacology & Pharmacy (Source: Thomson Reuters Journal Citation Reports 2015) Circulation: A figure is not disclosed. Distribution: It is available via subscription.  Aims of the Journal: The journal evaluates molecules, signal pathways, receptors and other therapeutic targets and their potential as candidates for drug development. Articles in this journal focus on the molecular level and should not include clinical information on specific drugs. Expert Opinion on Therapeutic Targets is a MEDLINE-indexed, peer-reviewed, international journal publishing review articles and original papers on novel molecular targets, with the aim of providing expert opinion on the scope for future drug development and the impact on drug discovery.  Editors welcome reviews covering novel disease targets at the molecular level and their implications for future drug development and original research papers reporting results of target selection and validation studies and basic mechanism of action studies for investigative and marketed drugs. Readership: Scientists, managers and decision makers in the pharmaceutical industry, academic researchers working in the field of molecular medicine and others closely involved in R&D. Manuscript Submission: Information for contributors can be found here and here. Other information: There is no generic email address. The Editorial Board can be found here.